Global Burn Ointment Market : Key Developments
In August 2022, MediWound, a pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has accepted Biologics License Application (BLA) for the company’s NexoBrid, a cream used in the treatment of burns.
Burn Ointment Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients